
Good healthcare requires good evidence
Good randomized controlled trials (RCTs) provide reliable evidence that enables informed changes in healthcare practice. It must be made easier to do good RCTs to inform future care.
The Good Clinical Trials Collaborative was set up to develop guidance to promote and enable good RCTs. Our draft guidance consultation ran from 4 August to 30 September 2021 and was accessed over 2000 times in more than 120 countries.
The English-language revised draft is now available in the Guidance section and by PDF download. We expect to publish the final guidance, following independent review, later in 2022, alongside updated translated versions.
Keep up to date
To follow the progress of the Good Clinical Trials Collaborative, share your email below for subscriber upates.
You can request that your data be removed at any time by contacting dpo@protas.co.uk
.png)